Revenue from Contract with Customer, Excluding Assessed Tax of KESTRA MEDICAL TECHNOLOGIES, LTD. from 30 Apr 2024 to 31 Jan 2026

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
KESTRA MEDICAL TECHNOLOGIES, LTD. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 30 Apr 2024 to 31 Jan 2026.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Jan 2026 was $24,552,000, a 63% increase year-over-year.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 31 Jan 2026 was $83,721,000.
  • KESTRA MEDICAL TECHNOLOGIES, LTD. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $59,815,000, a 115% increase from 2023.
Source SEC data
View on sec.gov
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)

KESTRA MEDICAL TECHNOLOGIES, LTD. Quarterly Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $83,721,000 $24,552,000 +$9,462,000 +63% 01 Nov 2025 31 Jan 2026 10-Q 17 Mar 2026 2026 Q3
Q3 2025 $74,259,000 $22,565,000 +$7,855,000 +53% 01 Aug 2025 31 Oct 2025 10-Q 11 Dec 2025 2025 Q2
Q2 2025 $66,404,000 $19,371,000 +$6,589,000 +52% 01 May 2025 31 Jul 2025 10-Q 12 Sep 2025 2025 Q1
Q1 2025 $59,815,000 $17,233,000 01 Feb 2025 30 Apr 2025 10-K 17 Jul 2025 2025 FY
Q4 2024 $15,090,000 01 Nov 2024 31 Jan 2025 10-Q 17 Mar 2026 2026 Q3
Q3 2024 $14,710,000 01 Aug 2024 31 Oct 2024 10-Q 11 Dec 2025 2025 Q2
Q2 2024 $12,782,000 01 May 2024 31 Jul 2024 10-Q 12 Sep 2025 2025 Q1

KESTRA MEDICAL TECHNOLOGIES, LTD. Annual Revenue from Contract with Customer, Excluding Assessed Tax (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $59,815,000 +$32,001,000 +115% 01 May 2024 30 Apr 2025 10-K 17 Jul 2025 2025 FY
2023 $27,814,000 01 May 2023 30 Apr 2024 10-K 17 Jul 2025 2025 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.